-transparent.png){kind=logo}
Growth hormone (GH) secretory patterns were studied in a patient with ectopic growth hormone releasing factor (GRF) secretion and in normal men given continuous infusions of human growth hormone releasing factor (1-40)-OH (hGRF-40). In the patient with ectopic GRF secretion, GH secretion was pulsatile despite continuously elevated immunoreactive GRF levels. To determine if pulsatile GH secretion is maintained in normal subjects, we administered to six healthy young men vehicle or hGRF-40, 2 ng/kg per min, for 24 h and gave a supramaximal intravenous bolus dose of hGRF-40, 3.3 micrograms/kg, after 23.5 h of infusion. hGRF-40 infusion resulted in greater GH secretion than did vehicle infusion and pulsatile GH secretion was maintained throughout hGRF-40 infusion. During the 23.5 h of vehicle infusion, total GH secretion (microgram; mean +/- SEM) was 634 +/- 151 compared with 1,576 +/- 284 during hGRF-40 infusion (P = 0.042). The GH response to the intravenous bolus of hGRF-40 was greater after vehicle infusion than after hGRF-40 infusion; 877 +/- 170 and 386 +/- 125 micrograms of GH was secreted after the bolus on vehicle and hGRF-40 days, respectively (P = 0.015). The total amount of GH secreted during the 25.5 h of the two study days was not different; 1,504 +/- 260 and 1,952 +/- 383 micrograms were secreted during vehicle and hGRF-40 days, respectively (P = 0.36). Not only was pulsatile GH secretion maintained during hGRF-40 infusion, but there was augmentation of naturally occurring GH pulses, which is in contrast to the effect of gonadotropin-releasing hormone on gonadotropin secretion. We suggest that GH pulses are a result of GRF secretion that is associated with a diminution or withdrawal of somatostatin secretion.
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
January 1986,
Neuroendocrinology,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
January 1989,
Acta paediatrica Scandinavica. Supplement,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
May 1984,
Endocrinology,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
December 1984,
Endocrinologia japonica,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
June 1988,
Nihon Ika Daigaku zasshi,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
October 1984,
Clinical endocrinology,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
February 1988,
Neuroendocrinology,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
September 1985,
Clinical endocrinology,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
October 1966,
The Journal of clinical endocrinology and metabolism,
M L Vance, and
D L Kaiser, and
W S Evans, and
R Furlanetto, and
W Vale, and
J Rivier, and
M O Thorner
September 1990,
The Journal of clinical endocrinology and metabolism,
